Oncology and Hematology

Episodes 1-1 of 1

• 

  RestartResume

  Addressing CKM Mortality & Morbidity in Patients With CKD and T2D: The Role of Combined ns-MRA & SGLT2i Therapy

  RestartResume

  Addressing CKM Mortality & Morbidity in Patients With CKD and T2D: The Role of Combined ns-MRA & SGLT2i Therapy

  CME/CE

  Addressing CKM Mortality & Morbidity in Patients With CKD and T2D: The Role of Combined ns-MRA & SGLT2i Therapy

  0.50 credits

  • 

    

    Rajiv Agarwal, MBBS, MD, FASN, BRCU

  • 

    

    Amy Mottl, MD, MPH

  • 

    

    Muthiah Vaduganathan, MD, MPH

  0.50 credits